Nutrineal Pd 4

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin, the active ingredient in Nutrineal Pd 4, is an amino acid supplement presented as a nutritional support product for intraperitoneal use. It provides essential amino acids that may support patients requiring specialized nutritional therapy.

GNH USA supplies Nutrineal Pd 4 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

Nutrineal Pd 4 is used as part of amino‑acid based nutritional support for patients with complex metabolic needs. - Post‑operative recovery: helps maintain nitrogen balance and supports tissue repair. - Chronic kidney disease requiring dialysis: supplies essential amino acids that are not adequately removed by dialysis. - Severe malnutrition or cachexia: contributes to protein synthesis and energy provision. - Inborn‑born metabolic disorders: provides a defined mixture of amino acids for metabolic control.

Adverse reactions are reported infrequently but may occur with intraperitoneal amino‑acid solutions.

Common Side Effects: - Mild abdominal discomfort or distension. - Transient nausea or vomiting. - Localized irritation at the infusion site. - Low‑grade fever. - Mild electrolyte shifts (e.g., potassium).

Serious or Rare Side Effects: - Peritoneal infection (peritonitis). - Severe allergic reaction or anaphylaxis. - Significant electrolyte imbalance. - Metabolic acidosis. - Hyperammonemia. - Unexpected rise in serum amino‑acid levels.

When using Nutrineal Pd 4, clinicians should assess patient suitability and monitor relevant clinical parameters. - Renal function: evaluate baseline creatinine and adjust therapy as needed. - Hepatic function: monitor liver enzymes for potential metabolic impact. - Electrolyte balance: check serum electrolytes regularly. - Infection risk: observe for signs of peritonitis during intraperitoneal administration. - Nutritional status: ensure the formulation matches the patient’s overall protein goals. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Amino‑acid solutions can interact with other intravenous therapies and affect laboratory measurements.

Major Interactions (Avoid): - High‑dose potassium supplements: may exacerbate hyperkalemia when combined with amino‑acid infusion. - Certain nephrotoxic antibiotics (e.g., aminoglycosides): increased risk of renal injury.

Moderate Interactions (Monitor Closely): - Loop diuretics: can alter electrolyte balance during therapy. - Insulin therapy: amino acids may affect glucose metabolism, requiring dose adjustments. - Blood‑type compatible blood products: concurrent infusion may affect plasma amino‑acid measurements. - Parenteral lipid emulsions: may require timing adjustments to avoid precipitation.